Proprietary Scoring

GLP-1 Response Predictor Score.

Which GLP-1 medication has the best response profile — and for whom? We score each major GLP-1 drug across five evidence-based dimensions.

ⓘ For informational purposes only — not medical advice.

Scoring Methodology

Each drug is scored across 5 dimensions (20 points each, 100 total) using published clinical trial data and Biomeme's proprietary mRNA monitoring compatibility assessment.

mRNA Monitoring

Weight Loss Efficacy

Tolerability

CV Evidence

Muscle Preservation

Rank	Drug	Score	mRNA Monitoring	Weight Loss Efficacy	Tolerability	CV Evidence	Muscle Preservation
#1	Mounjaro Tirzepatide	83 B+	18 /20	20 /20	15 /20	16 /20	14 /20	Details
#2	Wegovy Semaglutide 2.4 mg	83 B+	19 /20	16 /20	16 /20	19 /20	13 /20	Details
#3	Ozempic Semaglutide 0.5–2.0 mg	82 B+	19 /20	14 /20	17 /20	18 /20	14 /20	Details
#4	Zepbound Tirzepatide	81 B+	18 /20	20 /20	15 /20	14 /20	14 /20	Details
#5	Rybelsus Oral Semaglutide	76 B	17 /20	11 /20	18 /20	15 /20	15 /20	Details
#6	Victoza Liraglutide 1.8 mg	71 B-	15 /20	8 /20	15 /20	17 /20	16 /20	Details
#7	Saxenda Liraglutide 3.0 mg	68 C+	15 /20	10 /20	14 /20	14 /20	15 /20	Details

83 B+

Mounjaro

Tirzepatide

Dual GIP/GLP-1 agonist with the highest weight loss efficacy in trials.

83 B+

Wegovy

Semaglutide 2.4 mg

The weight management formulation with the strongest cardiovascular evidence.

82 B+

Ozempic

Semaglutide 0.5–2.0 mg

The most recognized GLP-1 brand — proven glycemic and weight management.

81 B+

Zepbound

Tirzepatide

Tirzepatide branded for weight management — same molecule as Mounjaro.

76 B

Rybelsus

Oral Semaglutide

The only oral GLP-1 — needle-free convenience with moderate efficacy.

71 B-

Victoza

Liraglutide 1.8 mg

The proven daily GLP-1 for diabetes with established cardiovascular benefit.

68 C+

Saxenda

Liraglutide 3.0 mg

First-generation daily GLP-1 for weight management — effective but superseded.

Frequently Asked Questions

What is a GLP-1 receptor agonist?

GLP-1 receptor agonists are a class of medications that mimic the incretin hormone GLP-1, enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite. They are FDA-approved for type 2 diabetes and/or chronic weight management.

How is the GLP-1 Response Predictor Score calculated?

Each drug is scored across five dimensions (20 points each, 100 total): mRNA monitoring compatibility (Biomeme proprietary), weight loss efficacy (published trial data), tolerability (inverse of discontinuation rate), cardiovascular evidence strength, and muscle preservation (inverse of lean mass loss). Scores are based on published clinical trial data and Biomeme's transcriptomic monitoring capabilities.

What does the mRNA Monitoring score mean?

This dimension reflects how well a drug's molecular response can be tracked using Biomeme's transcriptomic monitoring platform. Drugs with well-characterized gene expression pathways score higher because mRNA monitoring can provide actionable molecular feedback on therapeutic response.

Should I choose my GLP-1 medication based on this score?

No. This scoring framework is for informational purposes and does not constitute medical advice. Medication selection should be made in consultation with a qualified healthcare provider based on your individual medical history, insurance coverage, and treatment goals.

Monitor Your GLP-1 Response.

Don't guess whether your medication is working. Biomeme's GLP-1 Response Panel tracks molecular changes in real time.

Learn More Back to Wellness